Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder
Trial Summary
What is the purpose of this trial?
This is a pilot randomized controlled trial to assess the impact of a first-line treatment for posttraumatic stress disorder (PTSD) (Cognitive Processing Therapy; CPT) versus waitlist control on mechanisms of cardiovascular disease (CVD) risk. Further, this study will test the hypothesis that CPT reduces CVD risk through its effects on inflammation and autonomic function and that these changes are driven by changes in stress-related neural activity (SNA)
Will I have to stop taking my current medications?
The trial requires that you do not change your psychiatric or cardiovascular medications within 4 weeks before starting, meaning you should be on a stable regimen. However, if you are taking certain CVD medications like beta-blockers or high-intensity statins, you may not be eligible to participate.
What data supports the effectiveness of the treatment Cognitive Processing Therapy (CPT) for Post-Traumatic Stress Disorder (PTSD)?
Cognitive Processing Therapy (CPT) has been shown to significantly reduce PTSD symptoms in various settings, including among women in residential treatment and sexual assault survivors, with improvements maintained for months. It is also widely used by the Department of Veterans Affairs, demonstrating solid improvements in PTSD and depression symptoms among veterans.12345
Is cognitive processing therapy (CPT) safe for humans?
Cognitive processing therapy (CPT) is widely regarded as a safe treatment for post-traumatic stress disorder (PTSD) and has been implemented in various settings, including the Department of Veterans Affairs, with positive outcomes. It is considered a first-line treatment for PTSD and has been shown to be effective in reducing symptoms without significant safety concerns.12356
How is Cognitive Processing Therapy (CPT) different from other treatments for PTSD?
Cognitive Processing Therapy (CPT) is unique because it focuses on helping individuals challenge and change unhelpful beliefs related to their trauma, using a structured approach that includes education, exposure, and cognitive components. It can be delivered in both group and individual formats, making it versatile for different settings and populations.12347
Eligibility Criteria
This trial is for individuals with PTSD to see if Cognitive Processing Therapy (CPT) can lower their risk of heart disease. Participants should be diagnosed with PTSD but not currently receiving CPT. There's no mention of specific exclusions, so general health requirements likely apply.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete surveys, brain and peripheral imaging, and resting measures of autonomic function
Treatment
Participants receive Cognitive Processing Therapy (CPT) via telehealth
Post-treatment Assessment
Participants attend a post-treatment visit with the same assessments as baseline
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Cognitive Processing Therapy (Behavioral Intervention)
Cognitive Processing Therapy is already approved in United States, European Union for the following indications:
- Posttraumatic Stress Disorder (PTSD)
- Posttraumatic Stress Disorder (PTSD)